Related Experiment Video
Updated: May 12, 2026
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
The effect of dopamine on MPTP-induced rotarod disability
Scott Ayton1, Jessica L George, Paul A Adlard
1Florey Institute for Neuroscience and Mental Health, Kenneth Myer Building, University of Melbourne, Parkville, Australia.
Unlabelled:
Dopamine depletion in Parkinson's disease (PD) results in bradykinesia and tremor. Therapeutic administration of the dopamine precursor, l-Dopa, alleviates these symptoms but dyskinesia's can manifest with chronic treatment. In the MPTP toxin mouse model of PD, lesion severity is often assessed by the rotarod behavioral assay. Dopamine depletion by MPTP is thought to induce rotarod behavioral decline. Here we surveyed rotarod behavior and striatal dopamine at timed intervals post-MPTP. Paradoxically, rotarod disability coincided with gradual striatal dopamine restoration. l-Dopa supplementation exacerbated rotarod disability, whereas dopamine antagonism restored performance.
Conclusion:
dopamine restoration, not depletion, precipitates rotarod disability after MPTP intoxication, and caution should be applied when using this assay for MPTP.
Insights
Parkinson's disease (PD) models show that dopamine restoration, not depletion, causes rotarod test disability. Dopamine antagonism improved performance, suggesting caution when using this assay for MPTP-induced PD models.
Area of Science:
- Neuroscience
- Pharmacology
- Animal Models
Background:
- Parkinson's disease (PD) involves dopamine depletion, causing motor deficits like bradykinesia and tremor.
- L-Dopa therapy helps symptoms but can lead to dyskinesias with chronic use.
- The MPTP mouse model is used to study PD, with rotarod assay assessing lesion severity.
Purpose of the Study:
- To investigate the relationship between striatal dopamine levels and rotarod performance after MPTP intoxication.
- To clarify the role of dopamine restoration versus depletion in motor deficits in the MPTP model.
Main Methods:
- Mice were administered MPTP to induce Parkinsonism.
- Rotarod behavior and striatal dopamine levels were measured at timed intervals post-MPTP.
- Effects of l-Dopa administration and dopamine antagonism on rotarod performance were assessed.
Main Results:
- Rotarod test disability paradoxically correlated with gradual striatal dopamine restoration after MPTP.
- L-Dopa supplementation worsened rotarod performance.
- Dopamine antagonism improved rotarod performance.
Conclusions:
- Dopamine restoration, rather than depletion, appears to precipitate rotarod disability in the MPTP mouse model.
- Caution is advised when interpreting rotarod assay results for MPTP-induced Parkinsonism, as dopamine recovery may confound outcomes.
